Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Dec 4, 2022
Date Accepted: Nov 20, 2023

The final, peer-reviewed published version of this preprint can be found here:

Narrowing the Patient–Physician Gap Based on Self-Reporting and Monthly Hepatologist Feedback for Patients With Alcohol-Related Liver Disease: Interventional Pilot Study Using a Journaling Smartphone App

Yamashiki N, Kawabata K, Murata M, Ikeda S, Fujimaki T, Suwa K, Seki T, Aramaki E, Naganuma M

Narrowing the Patient–Physician Gap Based on Self-Reporting and Monthly Hepatologist Feedback for Patients With Alcohol-Related Liver Disease: Interventional Pilot Study Using a Journaling Smartphone App

JMIR Form Res 2023;7:e44762

DOI: 10.2196/44762

PMID: 38113066

PMCID: 10762609

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Narrowing the patient–specialist gap: Pilot study of a diary smartphone-app for patients with alcohol-related liver disease

  • Noriyo Yamashiki; 
  • Kyoko Kawabata; 
  • Miki Murata; 
  • Shunichiro Ikeda; 
  • Takako Fujimaki; 
  • Kanehiko Suwa; 
  • Toshihito Seki; 
  • Eiji Aramaki; 
  • Makoto Naganuma

ABSTRACT

Background:

Screening and intervention for alcohol use disorders (AUD) are recommended to improve alcohol-related liver disease (ALD) patient prognosis. Most patients’ smartphone application (app) diaries record drinking behavior for self-monitoring, but such data might be useful by treating teams.

Objective:

Aims of this study were to assess the use of a smartphone-app as a recording diary and to evaluate the usability of this tool for ALD patients.

Methods:

This pilot study used a newly developed smartphone journaling app for patients, with input data that physicians can review. After ALD patients were screened for harmful alcohol use, some were invited to use the smartphone journaling app for 8 weeks. Their self-reported alcohol intake, symptoms, and laboratory data were recorded at entry, week 4, and week 8. Later, their recorded data were reviewed by outpatient clinic physicians to evaluate changes in alcohol consumption, laboratory data, and app usage.

Results:

Of 14 patients agreeing to participate, 10 completed 8-week follow-up with diary input rates between 44% and 100% of expected days. Two withdrew from clinical follow-up. Two others never used the smartphone journaling app. Using the doctor’s view, a treating physician gave feedback comments to patients at each visit. Self-reported alcohol consumption dropped from baseline (100 ±70 g) to week 4 (13±25 g, p<0.01) and remained lower to week 8 (13±23 g). Five patients reported complete abstinence during the study. During the study period, decreases in total bilirubin (3.0±2.4 to 2.4±1.9 mg/dL, p=0.01) and increases in serum albumin (3.0±0.9 to 3.3±0.8 g/dL, p<0.01) were recorded.

Conclusions:

These pilot study findings revealed that the smartphone journaling app used by both patients and treating physicians produced short-term reduced drinking and enhanced patient motivation.


 Citation

Please cite as:

Yamashiki N, Kawabata K, Murata M, Ikeda S, Fujimaki T, Suwa K, Seki T, Aramaki E, Naganuma M

Narrowing the Patient–Physician Gap Based on Self-Reporting and Monthly Hepatologist Feedback for Patients With Alcohol-Related Liver Disease: Interventional Pilot Study Using a Journaling Smartphone App

JMIR Form Res 2023;7:e44762

DOI: 10.2196/44762

PMID: 38113066

PMCID: 10762609

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.